Abstract:Berberine is a bioactive isoquinoline alkaloid derived from many plants. Although berberine has been shown to inhibit growth and induce apoptosis of several tumor cell lines, its poor absorption and moderate activity hamper its full therapeutic potential. Here, we describe the synthesis of a series of 9-O-substituted berberine derivatives with improved antiproliferative and apoptosis-inducing activities. An analysis of novel berberine derivatives by EPR spectroscopy confirmed their similar photosensitivity and analogous behavior upon UVA irradiation as berberine, supporting their potential to generate ROS. Improved antitumor activity of novel berberine derivatives was revealed by MTT assay, by flow cytometry and by detection of apoptotic DNA fragmentation and caspase-3 activation, respectively. We showed that novel berberine derivatives are potent inhibitors of growth of HeLa and HL-60 tumor cell lines with IC50 values ranging from 0.7 to 16.7 μM for HL-60 cells and 36 to >200 μM for HeLa cells after 48 h treatment. Further cell cycle analysis showed that the observed inhibition of growth of HL-60 cells treated with berberine derivatives was due to arresting these cells in the G2/M and S phases. Most strikingly, we found that berberine derivative 3 (9-(3-bromopropoxy)-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a] isoquinolin-7-ylium bromide) possesses 30-fold superior antiproliferative activity with an IC50 value of 0.7 μM and 6-fold higher apoptosis-inducing activity in HL-60 leukemia cells compared to berberine. Therefore, further studies are merited of the antitumor activity in leukemia cells of this berberine derivative.

Synthesis of 8-Alkyl-13-bromo-berberine Hydrochloride Derivatives and Their Effect on Proliferation of Human HepG2 Cell Line

Inhibitory Effect of Berberine Α-Hydroxy Β-Decanoylethyl Sulfonate on MDA-MB-231 Cells in Vivo and in Vitro

Synthetic and antitumor comparison of 9- O -alkylated and carbohydrate-modified berberine derivatives

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Structural modification of berberine alkaloid and their hypoglycemic activity

Synthesis and Antimicrobial Activity of 8-Alkylberberine Derivatives with a Long Aliphatic Chain

Syntheses and Structure-Activity Relationships in Growth Inhibition Activity against Human Cancer Cell Lines of 12 Substituted Berberine Derivatives

Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives

Synthesis and Cytotoxicity Evaluation of 13-N-alkyl Berberine and Palmatine Analogues As Anticancer Agents.

Development of Novel 9-O-substituted-13-octylberberine Derivatives As Potential Anti-Hepatocellular Carcinoma Agents

Synthesis and Anticancer Activity of Novel 9,13-Disubstituted Berberine Derivatives

Design, Synthesis, and Anticancer Activity of Novel Berberine Derivatives Prepared Via CuAAC "click" Chemistry As Potential Anticancer Agents.

In Vitro Antitumor Efficacy of Berberine: Solid Lipid Nanoparticles Against Human HepG2, Huh7 and EC9706 Cancer Cell Lines

Berberine derivatives with a long alkyl chain branched by hydroxyl group and methoxycarbonyl group at 9-position show improved anti-proliferation activity and membrane permeability in A549 cells

Design, Synthesis and Biological Evaluation of Novel 9-N-substituted-13-alkylberberine Derivatives from Chinese Medicine As Anti-Hepatocellular Carcinoma Agents.

Synthesis and antitumor activity in vitro of novel berbamine derivatives

Design, Synthesis and Biological Evaluation of Novel Nitric Oxide-Donating Protoberberine Derivatives As Antitumor Agents.

9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity

Synthesis Of 8-Alkylberberine

In Vitro and in Vivo Antitumor Efficacy of Berberine-Nanostructured Lipid Carriers Against H22 Tumor

Anti-hepatocarcinoma Effects of Berberine-Nanostructured Lipid Carriers Against Human HepG2, Huh7, and EC9706 Cancer Cell Lines